X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (734) 734
Patent (186) 186
Publication (14) 14
Conference Proceeding (10) 10
Dissertation (4) 4
Book Chapter (3) 3
Book / eBook (2) 2
Book Review (1) 1
Data Set (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (299) 299
index medicus (230) 230
male (211) 211
female (193) 193
middle aged (168) 168
oncology (158) 158
aged (155) 155
physics (148) 148
adult (116) 116
chemistry (109) 109
cancer (107) 107
metallurgy (105) 105
medicine & public health (103) 103
dyes (92) 92
adhesives (91) 91
miscellaneous applications of materials (91) 91
miscellaneous compositions (91) 91
natural resins (91) 91
paints (91) 91
polishes (91) 91
chemotherapy (82) 82
optics (82) 82
adhesive processes not provided for elsewhere (78) 78
non-mechanical aspects of adhesive processes in general (78) 78
use of materials as adhesives (78) 78
performing operations (73) 73
transporting (73) 73
optical elements, systems, or apparatus (68) 68
analysis (67) 67
surgical oncology (65) 65
surgery (64) 64
retrospective studies (61) 61
aged, 80 and over (58) 58
prognosis (58) 58
stomach neoplasms - pathology (58) 58
layered products (57) 57
layered products, i.e. products built-up of strata of flat ornon-flat, e.g. cellular or honeycomb, form (57) 57
animals (54) 54
care and treatment (54) 54
calculating (50) 50
computing (50) 50
counting (50) 50
electric digital data processing (50) 50
electricity (48) 48
gastric cancer (48) 48
gastroenterology & hepatology (48) 48
treatment outcome (48) 48
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
biochemistry & molecular biology (44) 44
metastasis (44) 44
research (44) 44
compositions based thereon (43) 43
organic macromolecular compounds (43) 43
their preparation or chemical working-up (43) 43
pathology (42) 42
cancer research (40) 40
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (39) 39
frequency-changing (39) 39
neoplasm staging (39) 39
non-linear optics (39) 39
optical analogue/digital converters (39) 39
optical logic elements (39) 39
stomach cancer (39) 39
techniques or procedures for the operation thereof (39) 39
basic electric elements (37) 37
gastroenterology (37) 37
health aspects (36) 36
use of inorganic or non-macromolecular organic substances ascompounding ingredients (36) 36
immunohistochemistry (35) 35
carcinoma (34) 34
survival rate (34) 34
stomach neoplasms - drug therapy (33) 33
risk factors (32) 32
stomach neoplasms - genetics (32) 32
adenocarcinoma (31) 31
colorectal cancer (31) 31
japan (31) 31
mice (31) 31
drug combinations (30) 30
fluorouracil (29) 29
electric solid state devices not otherwise provided for (28) 28
patients (28) 28
semiconductor devices (28) 28
trial (28) 28
abdominal surgery (27) 27
cisplatin (27) 27
control or regulating systems in general (27) 27
controlling (27) 27
expression (27) 27
functional elements of such systems (27) 27
monitoring or testing arrangements for such systems orelements (27) 27
regulating (27) 27
follow-up studies (26) 26
gastric carcinoma (26) 26
radiotherapy (26) 26
advertising (25) 25
cryptography (25) 25
display (25) 25
displaying (25) 25
education (25) 25
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 919 - 926
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 631 - 639
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2017, Volume 20, Issue 4, pp. 640 - 645
Journal Article
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2016, Volume 21, Issue 4, pp. 668 - 675
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4438 - 4444
Journal Article
Cancer Science, ISSN 1347-9032, 07/2014, Volume 105, Issue 7, pp. 812 - 817
This multicenter phase II study first investigated the efficacy and safety of nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) when given every 3 weeks... 
phase II | triweekly | Gastric cancer | nab‐paclitaxel | second‐line chemotherapy | Second-line chemotherapy | nab-paclitaxel | Phase II | Triweekly | PLUS CISPLATIN | CREMOPHOR-FREE | second-line chemotherapy | ARBEITSGEMEINSCHAFT INTERNISTISCHE ONKOLOGIE | SALVAGE CHEMOTHERAPY | SUPPORTIVE CARE | ONCOLOGY | COMPARING IRINOTECAN | COMBINATION CHEMOTHERAPY | 1ST-LINE THERAPY | SOLVENT-BASED PACLITAXEL | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Paclitaxel - adverse effects | Male | Stomach Neoplasms - pathology | Treatment Outcome | Stomach Neoplasms - drug therapy | Paclitaxel - therapeutic use | Albumins - therapeutic use | Disease-Free Survival | Antineoplastic Agents, Phytogenic - administration & dosage | Albumins - adverse effects | Leukopenia - chemically induced | Adult | Female | Aged | Antineoplastic Agents, Phytogenic - therapeutic use | Neutropenia - chemically induced | Stomach Neoplasms - mortality | Antineoplastic Agents, Phytogenic - adverse effects | Antimitotic agents | Relapse | Chemotherapy | Clinical trials | Albumin | Product development | Antineoplastic agents | Stomach cancer | Diseases | Cancer | Breast cancer | Metastasis | Neuropathy | Cancer therapies | Disease control | Survival | Blood | Nanoparticles | Lymphopenia | Paclitaxel | Drug dosages | Neutropenia | Pharmaceuticals | Index Medicus | Original
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2019, Volume 22, Issue 1, pp. 138 - 146
Journal Article
Gastric Cancer, ISSN 1436-3291, 10/2015, Volume 18, Issue 4, pp. 824 - 832
This multicenter, randomized phase II trial was conducted to compare the efficacy and safety of nimotuzumab plus irinotecan (N-IRI) versus irinotecan alone... 
Irinotecan | Anti-EGFR | Medicine & Public Health | Gastroenterology | Second-line therapy | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Advanced gastric cancer | Nimotuzumab | ADVANCED ESOPHAGOGASTRIC CANCER | MONOCLONAL-ANTIBODY H-R3 | CHEMOTHERAPY PLUS | CELL LUNG-CANCER | CAPECITABINE | GROWTH-FACTOR RECEPTOR | SUPPORTIVE CARE | CISPLATIN | ONCOLOGY | EGFR ANTIBODY | 1ST-LINE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Antibodies, Monoclonal, Humanized - administration & dosage | DNA Mutational Analysis | Polymerase Chain Reaction | Adult | Camptothecin - administration & dosage | Female | Adenocarcinoma - genetics | Camptothecin - analogs & derivatives | Genes, ras - genetics | Stomach Neoplasms - genetics | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Receptor, Epidermal Growth Factor - biosynthesis | Receptor, ErbB-2 - biosynthesis | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Stomach Neoplasms - mortality | Salvage Therapy - methods | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Cancer patients | Clinical trials | Product development | Antineoplastic agents | Stomach cancer | Cancer | Original
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2014, Volume 32, Issue 2, pp. 355 - 361
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 927 - 938
Journal Article